Detalhe da pesquisa
1.
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study.
Ann Oncol
; 34(4): 389-396, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36709039
2.
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study.
Ann Oncol
; 33(4): 416-425, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026412
3.
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients.
Ann Oncol
; 33(4): 434-444, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35066105
4.
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.
Ann Oncol
; 28(4): 784-790, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28104619
5.
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma.
Invest New Drugs
; 31(6): 1530-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24077982
6.
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria.
Eur J Cancer
; 88: 38-47, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29182990
7.
Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours.
Eur J Cancer
; 95: 68-74, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29635146
8.
Phase I study of temsirolimus in combination with cetuximab in patients with advanced solid tumours.
Eur J Cancer
; 81: 81-89, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618305
9.
Immune-related adverse events with immune checkpoint blockade: a comprehensive review.
Eur J Cancer
; 54: 139-148, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26765102
10.
Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy.
Lung Cancer
; 89(3): 306-10, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26160757